Skip to main content

Table 7 Inclusivity in relation to consideration of homelessness and contextual factors

From: Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: a systematic review

Guideline

Does the guideline mention that concurrent problems can increase risk of self-harm, suicide, violence, injury or offending behaviour?

Is the risk of criminal justice system/offending/prison for those affected mentioned?

Does the guideline recommend providing health care for prison offender in rehabilitation centre

Is the risk of homelessness for those affected mentioned?

Does the guideline provide suggestions for healthcare professionals to refer patients to housing assistance or homelessness services if patients are found at risk of homelessness

Does the screening mentions patient history of sexual or other forms of abuse?

Is there mention of or consideration about stigma and discrimination in healthcare setting?

Does the guideline mention the importance of working with voluntary, charity or No?

NICE 2011

(coexisting disorders) [37]

Yes

Yes

Yes, in case of diverted treatment

Yes

Yes

Yes

Yes

Yes

NICE 2016

(coexisting disorders) [38]

Yes

Yes

No

Yes

Yes

No

Yes

Yes

Australian government 2016 [39]

Yes

No

No

Yes

No

Yes

Yes

No

SIGN 2013 [47]

Yes

No

No

Yes

Yes

No

No

No

NICE 2014

[48]

No

No

No

No

No

No

Yes

Yes

WFSBP 2015 [49]

Yes

No

No

Yes

Yes

No

No

No

RANZCP 2016 [50]

Yes

Yes

No

Yes

Yes

No

Yes

Yes

BAP 2019 [51]

No

No

No

No

No

No

No

No

APA 2020 [52]

Yes

No

No

Yes

Yes

Yes

No

No

VA/DoD 2010 [53]

Yes

No

No

No

No

Yes, but as risk factor for suicide in patients with bipolar disorder

No

No

Singapore MOH 2011 [54]

Yes

No

No

No

No

No

No

No

NICE 2014 [55]

Yes

No

No

No

No

Yes

Yes

No

BAP 2016 [56]

Yes

No

No

No

No

No

No

No

CANMAT and ISBD 2018 [57]

Yes

No

No

No

No

No

No

No

BAP 2012 [40]

No

No

No

No

No

No

No

No

WFSBP 2017 [41]

Yes

No

No

No

No

No

No

No

gov.uk 2017 [42]

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

DGPPN and DG-Sucht 2017 [43]

No

No

No

No

No

No

No

No

NICE 2011 [44]

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

APA 2018 [45]

Yes

No

No

No

No

No

No

No

ASAM 2015 [46]

Yes

Yes

No

No

No

No

No

No

  1. AOD Alcohol and other drug, APA American Psychiatric Association, ASAM American society of addiction medicine, AUD alcohol use disorder, BAP British Association of psychopharmacology, CANMAT and ISBD Canadian Network for Mood and Anxiety Treatments and International Society for Bipolar Disorders, gov.UK United Kingdom guidelines on clinical management, DGPPN and DG-Sucht German Association for Psychiatry, Psychotherapy, and Psychosomatics and the German Association for Addiction Research and Therapy, NICE National Institute for Health and Care Excellence, RANZCP Royal Australian and New Zealand College of Psychiatrists, SIGN Scottish Intercollegiate Guidelines Network, Singapore MOH Singapore Ministry of Health, SMI Severe mental illness, SUD Substance use disorder, UK United Kingdom, US United States, VA/DoD Department of Veterans Affairs and The Department of Defense, WFSBP World Federation of Societies of Biological Psychiatry